|
ARDS patients (n=35) |
ARDS patients (n=35) |
Non-ARDS patients (n=53) |
Non-ARDS patients (n=53) |
|
|
Admission |
Day 5 of treatment |
Admission |
Day 5 of treatment |
p |
WBC (/µL) |
8109.1 ± 5749.5 |
8292.1 ± 4588.6 |
6665.5 ± 2151.8 |
6487.9
± 2169.9 |
0.1 / 0.02
|
Lymphocytes (/µL) |
960 ± 467.3 |
1188.6 ± 674.9 |
1978.1 ± 870.3 |
2198.8 ± 816.2 |
0.001 / 0.001 |
Neutrophils (/µL) |
6411.4 ± 5117.7 |
6466.6 ± 4424.9 |
4046.8 ± 1572.3 |
3630.6 ± 1571.8 |
0.002 / 0.001 |
NLR |
9.8 ± 11.9 |
8.6 ± 12.8 |
2.3 ± 1.1 |
1.8 ± 0.9 |
0.001 /
0.001 |
AST (U/L) |
42.9 ± 25.1 |
46.6 ± 52.2 |
26.4 ± 13.4 |
23.5 ± 10.4 |
0.001 / 0.003
|
ALT (U/L) |
34.1 ± 30.6 |
36.5 ± 26.9 |
28.5 ± 20.9 |
28.3 ± 20.8 |
0.3
/ 0.1 |
LDH (U/L) |
434.4 ± 180.1 |
464.1 ± 255.1 |
230.7 ± 65.6 |
214.6 ± 60.7 |
0.001 / 0.001 |
GGT (U/L) |
55.2 ± 44.6 |
56.1 ± 45.1 |
29.9 ± 20 |
31.7 ± 25.6 |
0.001 / 0.03
|
ALP (U/L) |
90.1 ± 55.1 |
67.6 ± 27.7 |
71.8 ± 26.9 |
70.1 ± 27.6 |
0.07
/ 0.7 |
Sodium (mmol/L) |
137.3 ± 4.9 |
142 ± 6.9 |
139.7 ± 2.8 |
139.9 ± 2.3 |
0.005 / 0.06 |
Potassium (mmol/L) |
4.1 ± 0.6 |
4.3 ± 0.6 |
4.2 ± 0.4 |
4.4 ± 0.4 |
0.171 / 0.3 |
Creatine (mg/dL) |
1.3 ± 1.4 |
1.5 ± 1.5 |
0.9 ± 0.5 |
0.8 ± 0.2 |
0.04 / 0.002
|
Prothrombin time (s) |
19.1 ± 9.6 |
17.2 ± 7.5 |
13.8 ± 2.1 |
13.1 ± 1.5 |
0.001 / 0.001
|
CRP (mg/dl) |
132.1 ± 92.4 |
40.4 ± 31 |
17.9 ± 28.3 |
6.7 ± 11.5 |
0.001 / 0.001 |
Troponin-I (ng/dl) |
160.5 ± 460.3 |
380.2 ± 1889.7 |
5.4 ± 7.6 |
1.8 ±
1.7 |
0.001 / 0.001
|
PaO2/FiO2
|
228.5 ± 58.8 |
296.8 ± 44.8 |
337.8 ± 29.5 |
341.3 ± 41.1 |
0.001 / 0.001 |
D-Dimer
(ng/ml)
|
2113.2 ± 2622.2
|
1169.8 ± 1310.8
|
534.9 ± 243.8
|
331.3 ± 135.2
|
0.001 / 0.001
|
Ferritin (ng/ml) |
742.4 ± 1204.9 |
401.6 ± 347.3 |
359.7 ± 143.1 |
180.6 ± 36.7 |
0.02 / 0.01 |
MCP-1 (pg/ml) |
246.3 ± 211.5 |
160.2 ± 134.8 |
30.1 ± 28.7 |
22.8 ±
18.6 |
0,001/ 0,001 |
SP-A (pg/ml) |
517.3 ± 414.3 |
259.8 ± 200.7 |
301.6 ± 306.9 |
100.5 ±
88.4 |
0,001 / 0,001 |